REG - Concurrent Tech. - Notice of Interim Results

Concurrent TechnologiesAnnouncement

09/08/2019 07:05

RNS Number : 4312I
Concurrent Technologies PLC
09 August 2019
 


9 August 2019
Concurrent Technologies Plc
(the 'Company')
 
Notification of Interim Results
 
Concurrent Technologies Plc (AIM: CNC), a world leading specialist in the design and manufacture of high-end embedded computer products for critical applications in the defence, aerospace, telecommunications, transportation, scientific and industrial markets, will announce interim results for the six months to 30 June 2019, on 10 September 2019.
 
Enquiries:
 



Concurrent Technologies Plc
 Jane Annear, Managing Director/CEO


 
+44 (0)1206 752626




 


 




Newgate (Financial PR)
 Bob Huxford
Fiona Norman


 
+44 (0)20 7653 9848

+44 (0)20 3757 6885




 


 




Cenkos Securities Plc (NOMAD)
 Neil McDonald
Peter Lynch




+44 (0)131 220 9771
+44 (0)131 220 9772



 
Note to Editors:
 
About Concurrent Technologies Plc
 
Concurrent Technologies Plc develops and manufactures high-end embedded computer products for use in a wide range of high performance, long life cycle applications within the telecommunications, defence, security, telemetry, scientific and aerospace markets, including applications within extremely harsh environments. The processor products feature Intel® processors, including the latest 8th generation Intel® Core™ processors, Intel® Xeon® and Intel® Atom™ processors.  The products are designed to be compliant with industry specifications and support many of today's leading embedded Operating Systems.  The products are sold world-wide.
 
For more information on Concurrent Technologies Plc and its products please visit www.gocct.com.
 
All trademarks, registered trademarks and trade names used in this announcement are the property of their respective owners.




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NORUWVRRKAAWRAR